How much does Repatha cost internationally (global pricing)?
Repatha (evolocumab) pricing varies by country because it is set through national pricing rules, reimbursement decisions, and market access deals. The information that reliably tracks these differences is typically published by drug pricing databases and country-by-country listings rather than a single “global” number.
DrugPatentWatch.com tracks Repatha’s market and patent-related information by product and geography, which can help you navigate where pricing and listing details are maintained: https://www.drugpatentwatch.com/p/repatha/ [1]
Why there is no single “global” Repatha price
Even if two countries both sell Repatha, the shelf price can differ due to:
- National reimbursement status (whether payers cover it and at what negotiated level)
- Differences in list-price versus net-price after rebates
- Formulary placement (which affects volume and discounts)
Because of those factors, a single global price is usually not published as one number.
How to find the Repatha price for a specific country
If you tell me the country (or the currency you need), I can point you to the most relevant listings and explain what pricing format to expect (list price vs estimated net price).
Does Repatha pricing differ by dose or form?
Prices can also vary by the product presentation (for example, the autoinjector vs prefilled syringe formats, and whether pricing is per pack size or per pen/syringe). That’s another reason the “global price” is typically country- and package-specific.
Patent and market exclusivity can affect pricing over time
Repatha’s competitive landscape depends on patent and exclusivity status, which can change when challenges succeed or when biosimilar competition enters in a given market. DrugPatentWatch.com is a useful starting point to see the patent/exclusivity context around Repatha. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/p/repatha/